GSK plc Decrease Through Classified As Held For Sale Rightofuse Assets
GSK plc (GSK) reported Decrease Through Classified As Held For Sale Rightofuse Assets of GBP 16.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:DecreaseThroughClassifiedAsHeldForSaleRightofuseAssets · last filed 2026-03-06
| Period end | Decrease Through Classified As Held For Sale Rightofuse Assets 12 month |
|---|---|
| 2025-12-31 | 16.00M GBP 20-F · filed 2026-03-06 |